What is the diagnosis and treatment approach for a patient presenting with symptoms of dysentery, including diarrhea, abdominal pain, and bloody stools?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dysentery Diagnosis and Treatment

For a patient presenting with dysentery (bloody diarrhea, fever, abdominal pain, tenesmus), obtain stool cultures for Salmonella, Shigella, Campylobacter, Yersinia, and Shiga toxin testing immediately, and initiate empiric antibiotics with azithromycin (or a fluoroquinolone based on local resistance patterns) only if the patient has documented fever in a medical setting with classic bacillary dysentery syndrome, is an infant <3 months old, or has recent international travel with fever ≥38.5°C. 1

Diagnostic Workup

Essential Clinical Features to Assess

  • Fever documentation: Temperature ≥38.5°C measured in a medical setting is a key indicator for empiric antibiotic therapy in dysentery 1
  • Stool characteristics: Frequent scant bloody stools with mucus, accompanied by tenesmus and abdominal cramps, suggest bacillary dysentery (typically Shigella) 1
  • Volume depletion signs: Assess for tachycardia, orthostasis, decreased urination, lethargy, decreased skin turgor, and dry mucous membranes 1
  • Travel history: Recent international travel within 3 days prior to symptom onset significantly alters management 1
  • Immunocompromised status: HIV/AIDS, immunosuppressive medications, or other immune deficiencies require broader diagnostic evaluation 1

Mandatory Laboratory Testing

  • Stool culture: Test for Salmonella, Shigella, Campylobacter, and Yersinia in all patients with fever, bloody stools, severe abdominal cramping, or signs of sepsis 1
  • Shiga toxin testing: STEC O157 should be assessed by culture on sorbitol-MacConkey agar, and non-O157 STEC detected by Shiga toxin or genomic assays—this is critical because antibiotics are contraindicated if STEC is identified 1
  • Blood cultures: Obtain from infants <3 months, patients with signs of septicemia, suspected enteric fever, or immunocompromised patients 1
  • Fecal inflammatory markers: Presence of fecal leukocytes, lactoferrin, or occult blood supports bacterial etiology 1

Special Diagnostic Considerations

  • Yersinia testing: Consider in patients with persistent right lower quadrant pain mimicking appendicitis, especially children with exposure to raw/undercooked pork 1
  • C. difficile testing: Required if patient received antibiotics within the preceding 8-12 weeks 1
  • Parasitic evaluation: Test for Entamoeba histolytica if symptoms persist ≥14 days or if patient is from an endemic region 1

Treatment Algorithm

Immediate Rehydration (All Patients)

  • Reduced osmolarity oral rehydration solution (ORS) is the cornerstone of treatment for mild to moderate dehydration, regardless of etiology 1, 2
  • Intravenous isotonic fluids (lactated Ringer's) for severe dehydration, shock, altered mental status, or inability to tolerate oral intake 1
  • Nasogastric ORS administration may be considered in patients with moderate dehydration who cannot tolerate oral intake 1

Empiric Antibiotic Therapy: When to Treat

Treat empirically in these specific scenarios ONLY:

  1. Infants <3 months of age with suspected bacterial etiology: Use third-generation cephalosporin 1, 2

  2. Classic bacillary dysentery syndrome: Ill immunocompetent patients with documented fever in a medical setting, abdominal pain, bloody diarrhea, and tenesmus presumptively due to Shigella 1

  3. Recent international travelers with temperature ≥38.5°C and/or signs of sepsis 1, 2

  4. Immunocompromised patients with severe illness and bloody diarrhea 1

  5. Suspected enteric fever with sepsis features: Treat empirically with broad-spectrum antibiotics after obtaining blood, stool, and urine cultures 1

Do NOT treat empirically in immunocompetent adults and children with bloody diarrhea while awaiting diagnostic results, except for the above scenarios 1

Antibiotic Selection

  • Adults: Azithromycin (preferred) or fluoroquinolone (ciprofloxacin), depending on local susceptibility patterns and travel history 1, 2

    • Azithromycin is strongly preferred due to high fluoroquinolone resistance in Campylobacter in many regions 2
    • Single-dose azithromycin 1000mg or 500mg daily for 3 days 2, 3
  • Children: Azithromycin based on local susceptibility patterns and travel history 1

    • Exception: Third-generation cephalosporin for infants <3 months or those with neurologic involvement 1, 2
  • Modify or discontinue antibiotics when a specific pathogen is identified from stool culture 1

Critical Contraindications

NEVER give antibiotics if STEC O157:H7 or other Shiga toxin 2-producing strains are suspected or confirmed—this significantly increases the risk of hemolytic uremic syndrome 1, 2, 3

  • Patients with STEC typically present with bloody diarrhea but are NOT febrile at presentation 1
  • Wait for Shiga toxin testing results before initiating antibiotics in bloody diarrhea without high fever 2, 3

Adjunctive Therapy

  • Antimotility agents (loperamide): May be used in immunocompetent adults with adequate hydration, but NEVER in children <18 years or any patient with fever/bloody diarrhea 2
  • Antiemetics (ondansetron): May facilitate oral rehydration in children >4 years 2
  • Probiotics: May reduce symptom duration in immunocompetent patients 2

Reassessment and Follow-Up

  • Clinical reevaluation is indicated if no improvement within 48-72 hours: Consider antibiotic resistance, inadequate rehydration, or noninfectious causes (inflammatory bowel disease, ischemic colitis) 1
  • Persistent symptoms ≥14 days: Reassess for parasitic infections (Giardia, Entamoeba histolytica), inflammatory bowel disease, or postinfectious irritable bowel syndrome 1
  • Follow-up stool testing: Generally not recommended after symptom resolution except when required by local health authorities for return to childcare or food-handling employment 1

Common Pitfalls to Avoid

  • Empiric antibiotics without fever documentation: Most immunocompetent patients with bloody diarrhea do not require antibiotics while awaiting culture results 1
  • Treating STEC with antibiotics: This increases hemolytic uremic syndrome risk—always obtain Shiga toxin testing before treating bloody diarrhea 1, 2, 3
  • Neglecting rehydration: ORS is the priority intervention and reduces mortality more effectively than antibiotics alone 1, 2
  • Treating asymptomatic contacts: Do not offer empiric antibiotics to contacts; advise infection control measures only 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Infectious Diarrhea with Facial Rash: Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Empiric Antibiotic Use in Diarrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.